Literature DB >> 16344284

TEM-21 extended-spectrum beta-lactamase in a clinical isolate of Alcaligenes faecalis from a nursing home.

Véronique Dubois, Corinne Arpin, Laure Coulange, Catherine André, Patrick Noury, Claudine Quentin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16344284     DOI： 10.1093/jac/dki450

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  5 in total

1.  Genomic Characterization of VIM Metallo-β-Lactamase-Producing Alcaligenes faecalis from Gaza, Palestine.

Authors:  Nahed Al Laham; Kalyan D Chavda; Astrid V Cienfuegos-Gallet; Barry N Kreiswirth; Liang Chen
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

Review 2.  Aminoglycoside modifying enzymes.

Authors:  Maria S Ramirez; Marcelo E Tolmasky
Journal:  Drug Resist Updat       Date:  2010-09-15       Impact factor: 18.500

3.  Molecular characterization of multidrug-resistance in Gram-negative bacteria from the Peshawar teaching hospital, Pakistan.

Authors:  A Masseron; L Poirel; B Jamil Ali; M A Syed; P Nordmann
Journal:  New Microbes New Infect       Date:  2019-10-11

4.  Extensively drug-resistant Alcaligenes faecalis infection.

Authors:  Chienhsiu Huang
Journal:  BMC Infect Dis       Date:  2020-11-11       Impact factor: 3.090

5.  Genomic and resistome analysis of Alcaligenes faecalis strain PGB1 by Nanopore MinION and Illumina Technologies.

Authors:  Jidong Lang; Yanju Li; Wenjuan Yang; Ruyi Dong; Yuebin Liang; Jia Liu; Lanyou Chen; Weiwei Wang; Binbin Ji; Geng Tian; Nanying Che; Bo Meng
Journal:  BMC Genomics       Date:  2022-04-20       Impact factor: 4.547
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.